Skip to main content

Allscripts Healthcare Solution Value Stock - Dividend - Research Selection

Allscripts healthcare solution

ISIN: US01988P1084 , WKN: 607917

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company\'s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company\'s Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Veradigm: You Can't Fall Off The Floor

2026-04-27
Veradigm (MDRX) at 20-year lows: turnaround, SEC filings, Nasdaq relisting catalyst, and valuation upside. Read here for a detailed investment analysis.

Veradigm avoids enforcement action in SEC probe

2026-02-25
The investigation began after the health IT company failed to comply with financial reporting requirements, which led to its delisting from the Nasdaq in early 2024.

Veradigm cut 15% of its workforce in 2025

2026-02-19
The health IT firm is also cutting back on offices and “low revenue” products as it works to get up to date on its financial filings with regulators, executives said during a call this week.

Veradigm Inc. (MDRX) Discusses Strategic Reset, Product Portfolio Decisions and Growth Initiatives Transcript

2026-02-18

Veradigm Provides Business and Strategy Update

2026-02-17
CHICAGO, February 17, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026.

$555+ Mn AI in Patient Scheduling Software Market Forecast to 2033 Featuring Veradigm, Epic Systems, Hyro, Assort Health, Notable, Voiceoc, Zocdoc, Relatient, and UnityAI

2026-02-17
The AI in patient scheduling software market is primed for growth, driven by the need to reduce inefficiencies and improve patient-centric care. Key opportunities include optimizing resource use, enhancing digital patient engagement, and facilitating telehealth. The rise of value-based care further amplifies AI scheduling adoption. AI in Patient Scheduling Software Market AI in Patient Scheduling Software Market Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "AI in Patient Scheduling Software Mar

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

2026-02-13
CHICAGO, February 13, 2026--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research.

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

2026-02-10
CHICAGO, February 10, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026.